Clinical Trials · NCT05567198
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Enrollment
- 100
- Start date
- Mar 2023
- Locations
- 1 site, United States
- Primary endpoint
- POI